Your browser doesn't support javascript.
loading
Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
Zhan, Yonghao; Chen, Zhicong; He, Shiming; Gong, Yanqing; He, Anbang; Li, Yifan; Zhang, Lianghao; Zhang, Xuepei; Fang, Dong; Li, Xuesong; Zhou, Liqun.
Afiliación
  • Zhan Y; Department of Urology, The Institute of Urology, Peking University First Hospital, Peking University, National Urological Cancer Center, No. 8 Xishiku street, Beijing, 100034, China.
  • Chen Z; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China.
  • He S; Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450003, China.
  • Gong Y; Department of Urology, The Institute of Urology, Peking University First Hospital, Peking University, National Urological Cancer Center, No. 8 Xishiku street, Beijing, 100034, China.
  • He A; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China.
  • Li Y; Department of Urology, The Institute of Urology, Peking University First Hospital, Peking University, National Urological Cancer Center, No. 8 Xishiku street, Beijing, 100034, China.
  • Zhang L; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China.
  • Zhang X; Department of Urology, The Institute of Urology, Peking University First Hospital, Peking University, National Urological Cancer Center, No. 8 Xishiku street, Beijing, 100034, China.
  • Fang D; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China.
  • Li X; Department of Urology, The Institute of Urology, Peking University First Hospital, Peking University, National Urological Cancer Center, No. 8 Xishiku street, Beijing, 100034, China.
  • Zhou L; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China.
Mol Cancer ; 22(1): 115, 2023 Jul 18.
Article en En | MEDLINE | ID: mdl-37464407

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido